alpha-chymotrypsin and Cholestasis--Intrahepatic

alpha-chymotrypsin has been researched along with Cholestasis--Intrahepatic* in 2 studies

Other Studies

2 other study(ies) available for alpha-chymotrypsin and Cholestasis--Intrahepatic

ArticleYear
Exocrine pancreatic function in children with progressive familial intrahepatic cholestasis type 2.
    Journal of pediatric gastroenterology and nutrition, 2006, Volume: 42, Issue:4

    In progressive familial intrahepatic cholestasis type 2 (PFIC-2), severe steatorrhea is often documented. However, pancreatic exocrine secretion has not yet been studied. In 14 children with PFIC-2, pancreatic function was assessed using standard fecal tests. Normal fecal lipase concentrations excluded isolated lipase deficiency. No differences in fecal elastase-1 concentrations and chymotrypsin activities were detected between PFIC-2 patients with or without steatorrhea, nor between these patients and healthy subjects. In conclusion, pancreatic exocrine function in patients with PFIC-2 is normal. Steatorrhea observed in those patients is not related to pancreatic insufficiency.

    Topics: Adolescent; Biomarkers; Child; Child, Preschool; Cholestasis, Intrahepatic; Chymotrypsin; Feces; Female; Humans; Infant; Lipase; Male; Pancreas, Exocrine; Pancreatic Elastase; Steatorrhea

2006
Normal pancreatic secretion in children with progressive familial intrahepatic cholestasis type 1.
    Scandinavian journal of gastroenterology, 2006, Volume: 41, Issue:12

    Progressive familial intrahepatic cholestasis type 1 (PFIC1) is a rare, autosomal, recessive, inherited disease resulting from mutations in the ATP8B1 gene which is expressed at high levels in the small intestine and pancreas and at lower levels in the liver. Given this expression pattern, patients might be expected to have a pancreatic phenotype. Although pancreatitis and steatorrhea have been reported in patients with PFIC1, the available data on pancreatic function are not fully convincing. Therefore, the objective of this study was to assess exocrine pancreatic function in patients with PFIC1.. Three subjects with a diagnosis of PFIC1 were included in the study. The diagnosis was confirmed by molecular analysis of ATP8B1. Prior to surgical treatment (biliary diversion), two patients had steatorrhea and in the third patient, a borderline value for fecal fat excretion was documented. In one patient, liver transplantation also was subsequently performed. Exocrine pancreatic secretion was assessed by the use of fecal elastase-1 and chymotrypsin tests. Fecal lipase concentrations were determined in order to exclude isolated lipase deficiency. Other typical diagnostic procedures were performed annually.. The results of the fecal tests were within the normal range. None of the three patients experienced any episodes that could be related to acute or chronic pancreatitis. Laboratory tests including serum amylase and lipase tests were always normal. Abdominal ultrasonography findings did not show any pancreatic pathology.. Pancreatic secretion in the study patients with progressive familial intrahepatic cholestasis type 1 was normal. The observed steatorrhea was not related to pancreatic insufficiency.

    Topics: Adenosine Triphosphatases; Adolescent; Adult; Child, Preschool; Cholestasis, Intrahepatic; Chymotrypsin; Feces; Female; Humans; Lipase; Male; Pancreas, Exocrine; Pancreatic Elastase

2006